BMY
$52.15
Revenue | $12222Mn |
Net Profits | $2201Mn |
Net Profit Margins | 18.01% |
Bristol-myers Squibb Co.’s revenue jumped 2.77% since last year same period to $12222Mn in the Q3 2025. On a quarterly growth basis, Bristol-myers Squibb Co. has generated -0.38% fall in its revenue since last 3-months.
Bristol-myers Squibb Co.’s net profit jumped 81.75% since last year same period to $2201Mn in the Q3 2025. On a quarterly growth basis, Bristol-myers Squibb Co. has generated 68.02% jump in its net profits since last 3-months.
Bristol-myers Squibb Co.’s net profit margin jumped 76.84% since last year same period to 18.01% in the Q3 2025. On a quarterly growth basis, Bristol-myers Squibb Co. has generated 68.66% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 1.69 |
EPS Estimate Current Year | 1.69 |
Bristol-myers Squibb Co.’s earning per share (EPS) estimates for the current quarter stand at 1.69 - a 53.64% jump from last quarter’s estimates.
Bristol-myers Squibb Co.’s earning per share (EPS) estimates for the current year stand at 1.69.
Earning Per Share (EPS) | 1.46 |
Dividend Per Share (DPS) | 0.62 |
Bristol-myers Squibb Co.’s earning per share (EPS) fell -29.47% since last year same period to 1.46 in the Q2 2025. This indicates that the Bristol-myers Squibb Co. has generated -29.47% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Bristol-myers Squibb Co. declared 0.62 dividend per share during the earnings announcement for Q2 2025.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-07-31 | 1.1 | 1.46 | 32.73% |
2025-04-24 | 1.5 | 1.8 | 20% |